← Evidence map

ArticleThe journal of prevention of Alzheimer's disease2026

Beyond amyloid positivity: Biological heterogeneity in the real-world use of lecanemab.

Michael S RafiiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42102503